France Neuromodulation Devices Market Outlook to 2025

France Neuromodulation Devices Market Outlook to 2025


  • Products Id :- GDMECC3540DB
  • |
  • Pages: 60
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

France Neuromodulation Devices Market Outlook to 2025

Summary

GlobalData's new report, France Neuromodulation Devices Market Outlook to 2025, provides key market data on the France Neuromodulation Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments-Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS).

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Neuromodulation Devices market segments-Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators (VNS)..

- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.

- 2017 company share and distribution share data for Neuromodulation Devices market.

- Global corporate-level profiles of key companies operating within the France Neuromodulation Devices market.

- Key players covered include Abbott Healthcare Pvt Ltd, Boston Scientific Corp, Medtronic plc and others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 What Is This Report About? 5

2.2 Neuromodulation Devices Market Segmentation 5

2.3 Definitions of Markets Covered in the Report 6

3 Neuromodulation Devices Market, France 7

3.1 Neuromodulation Devices Market, France, Revenue (USD m), 2015-2025 7

3.2 Neuromodulation Devices Market, France, Volume (Units), 2015-2025 10

3.3 Neuromodulation Devices Market, France, Average Price (USD ), 2015-2025 13

3.4 Neuromodulation Devices Market, France, Distribution Share by Revenue (USD m), 2017 15

3.5 Neuromodulation Devices Market, France, Company Share by Revenue (USD m), 2017 16

4 Overview of Key Companies in France, Neuromodulation Devices Market 18

4.1 Medtronic Plc 18

4.1.1 Company Overview 18

4.2 Boston Scientific Corp 18

4.2.1 Company Overview 18

4.3 Nevro Corp 18

4.3.1 Company Overview 18

4.4 LivaNova PLC 18

4.4.1 Company Overview 18

4.5 Abbott Laboratories 19

4.5.1 Company Overview 19

5 Neuromodulation Devices Market Pipeline Products 20

6 Financial Deals Landscape 24

6.1 Debt Offerings 24

6.1.1 Sanofi Prices First Tranche of Public Offering of Notes Due 2020 for USD1.2 Billion 24

6.1.2 Sanofi Prices Second Tranche of Public Offering of Notes Due 2020 for USD0.6 Billion 26

6.1.3 Sanofi Prices Third Tranche of Public Offering of 0.5% Notes Due 2023 for USD2.2 Billion 28

6.1.4 Sanofi Prices Fourth Tranche of Public Offering of 1% Notes Due 2026 for USD1.9 Billion 30

6.1.5 Sanofi Prices Fifth Tranche of Public Offering of 1.375% Notes Due 2030 for USD2.47 Billion 32

6.1.6 Sanofi Prices Sixth Tranche of Public Offering of 1.875% Notes Due 2038 for USD1.54 Billion 34

6.1.7 Visiomed Group Raises USD8.1 Million in First Tranche of Private Placement of Notes 36

7 Recent Developments 37

7.1 Corporate Communications 37

7.1.1 Jun 19, 2018: Sanofi appoints Jean-Baptiste Chasseloup de Chatillon Executive Vice President, Chief Financial Officer 37

7.1.2 May 08, 2018: Sanofi Announces Appointment of Mr. Charles Billard as Chief Financial Officer and Key Managerial Personnel 37

7.1.3 Apr 24, 2018: Sanofi Head of Global R&D Elias Zerhouni to retire; Company names John Reed to take over on July 1 37

7.1.4 Mar 06, 2018: Sanofi's Board of Directors Proposes Appointment of Emmanuel Babeau as New Independent Director 38

7.1.5 Jan 19, 2018: Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee 38

7.2 Financial Announcements 39

7.2.1 Mar 28, 2018: Sanofi: Pre-quarterly R esults C ommunication 39

7.2.2 Nov 02, 2017: Sanofi: Q3 2017 Business EPS up 1.1% at CER FY 2017 Guidance Confirmed 40

7.3 Other Significant Developments 46

7.3.1 May 28, 2018: Beactica Signs Three-Year Extension Agreement With Sanofi 46

7.3.2 Apr 27, 2018: Sanofi: First-quarter 2018 Business EPS up 1.4% at CER 46

7.3.3 Feb 07, 2018: Sanofi Delivers 2017 Business EPS in line with Guidance 51

8 Appendix 54

8.1 Research Methodology 55

8.1.1 Coverage 55

8.1.2 Secondary Research 55

8.1.3 Primary Research 56

8.1.4 Market Modeling and Forecasting 57

8.1.5 Company Share Analysis 58

8.1.6 Distribution Share Analysis 59

8.1.7 Benchmarking 59

8.2 GlobalData Consulting 59

8.3 Contact Us 60

8.4 Disclaimer 60

1.2 List of Figures

Figure 1: Neuromodulation Devices Market, France, Revenue (USD m), USD Constant, 2015-2025 7

Figure 2: Neuromodulation Devices Market, France, Volume (Units), 2015-2025 10

Figure 3: Neuromodulation Devices Market, France, Company Share (%) 2017 16

1.1 List of Tables

Table 1: Neuromodulation Devices Market, France, Revenue (USD m), USD Constant, 2015-2020 8

Table 2: Neuromodulation Devices Market, France, Revenue (USD m), USD Constant, 2021-2025 9

Table 3: Neuromodulation Devices Market, France, Volume (Units), 2015-2020 11

Table 4: Neuromodulation Devices Market, France, Volume (Units), 2021-2025 12

Table 5: Neuromodulation Devices Market, France, Average Price (USD ), 2015-2020 13

Table 6: Neuromodulation Devices Market, France, Average Price (USD ), 2021-2025 14

Table 7: Neuromodulation Devices Market, France, Distribution Share by Revenue (USD m), USD Constant, 2017 15

Table 8: Neuromodulation Devices Market, France, Company Share by Revenue (USD m), USD Constant, 2017 17

Table 9: Neuromodulation Devices Market Pipeline Products 20

Table 10: Sanofi Prices First Tranche of Public Offering of Notes Due 2020 for USD1.2 Billion 24

Table 11: Sanofi Prices Second Tranche of Public Offering of Notes Due 2020 for USD0.6 Billion 26

Table 12: Sanofi Prices Third Tranche of Public Offering of 0.5% Notes Due 2023 for USD2.2 Billion 28

Table 13: Sanofi Prices Fourth Tranche of Public Offering of 1% Notes Due 2026 for USD1.9 Billion 30

Table 14: Sanofi Prices Fifth Tranche of Public Offering of 1.375% Notes Due 2030 for USD2.47 Billion 32

Table 15: Sanofi Prices Sixth Tranche of Public Offering of 1.875% Notes Due 2038 for USD1.54 Billion 34

Table 16: Visiomed Group Raises USD8.1 Million in First Tranche of Private Placement of Notes 36

Table 17: Total Number of Primary Research Participants, Neurology Devices Market, by Country 57

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Medtronic Plc

Boston Scientific Corp

Nevro Corp

LivaNova PLC

Abbott Laboratories

Neurology Devices, Hydrocephalus shunts, Interventional Neuroradiology, Neurological Diagnostic and Monitoring Equipment, Neuromodulation Devices, Neurosurgical Products, Radiosurgery Systems, Value (USD), Volume (units), Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, Medtronic plc, Abbott Healthcare Pvt Ltd, Boston Scientific Corp, Natus Medical Incorporated, Stryker Corp, Nevro Corp, Cerenovus, Terumo Corp, LivaNova PLC , Nihon Kohden Corp, Penumbra Inc, Integra LifeSciences Corp, B. Braun Melsungen AG, Accuray Inc, Elekta AB

select a license
Single User License
USD 4995 INR 355594
Site License
USD 9990 INR 711188
Corporate User License
USD 14985 INR 1066782

NEWSLETTER BY CATEGORY




Testimonials

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com